TreeWAS – Variant ID: rs7660520

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C07 Malignant neoplasm of parotid gland	0.019	0.981	0.000
C12 Malignant neoplasm of pyriform sinus	0.018	0.982	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.018	0.982	0.000
C01 Malignant neoplasm of base of tongue	0.016	0.984	0.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.015	0.985	0.000
C10 Malignant neoplasm of oropharynx	0.014	0.986	0.000
C04 Malignant neoplasm of floor of mouth	0.014	0.986	0.000
C11 Malignant neoplasm of nasopharynx	0.014	0.986	0.000
C13 Malignant neoplasm of hypopharynx	0.014	0.986	0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.014	0.986	0.000
C06 Malignant neoplasm of other and unspecified parts of mouth	0.013	0.987	0.000
C03 Malignant neoplasm of gum	0.013	0.987	0.000
C08 Malignant neoplasm of other and unspecified major salivary glands	0.013	0.987	0.000
C05 Malignant neoplasm of palate	0.012	0.988	0.000
C10.9 Oropharynx, unspecified	0.012	0.988	0.000
C09 Malignant neoplasm of tonsil	0.012	0.988	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.012	0.988	0.000
C11.9 Nasopharynx, unspecified	0.012	0.988	0.000
C00 Malignant neoplasm of lip	0.012	0.988	0.000
C04.9 Floor of mouth, unspecified	0.012	0.988	0.000
M06.9 Rheumatoid arthritis, unspecified	0.011	0.989	0.000
C04.0 Anterior floor of mouth	0.011	0.989	0.000
C13.0 Postcricoid region	0.011	0.989	0.000
K62.8 Other specified diseases of anus and rectum	0.011	0.989	0.000
C14.0 Pharynx, unspecified	0.011	0.989	0.000
C10.8 Overlapping lesion of oropharynx	0.010	0.989	0.000
C10.4 Branchial cleft	0.010	0.989	0.000
C10.3 Posterior wall of oropharynx	0.010	0.989	0.000
C10.2 Lateral wall of oropharynx	0.010	0.989	0.000
C10.1 Anterior surface of epiglottis	0.010	0.989	0.000
C10.0 Vallecula	0.010	0.989	0.000
C04.8 Overlapping lesion of floor of mouth	0.010	0.989	0.000
C04.1 Lateral floor of mouth	0.010	0.989	0.000
C05.9 Palate, unspecified	0.010	0.989	0.000
C11.8 Overlapping lesion of nasopharynx	0.010	0.990	0.000
C11.3 Anterior wall of nasopharynx	0.010	0.990	0.000
C11.2 Lateral wall of nasopharynx	0.010	0.990	0.000
C11.1 Posterior wall of nasopharynx	0.010	0.990	0.000
C11.0 Superior wall of nasopharynx	0.010	0.990	0.000
C13.9 Hypopharynx, unspecified	0.010	0.990	0.000
C13.8 Overlapping lesion of hypopharynx	0.010	0.990	0.000
C13.2 Posterior wall of hypopharynx	0.010	0.990	0.000
C13.1 Aryepiglottic fold, hypopharyngeal aspect	0.010	0.990	0.000
C09.0 Tonsillar fossa	0.010	0.990	0.000
C14.8 Overlapping lesion of lip, oral cavity and pharynx	0.010	0.990	0.000
C14.2 Waldeyer's ring	0.010	0.990	0.000
C06.9 Mouth, unspecified	0.010	0.990	0.000
C06.8 Overlapping lesion of other and unspecified parts of mouth	0.009	0.990	0.000
C06.1 Vestibule of mouth	0.009	0.990	0.000
C06.2 Retromolar area	0.009	0.990	0.000
C03.9 Gum, unspecified	0.009	0.991	0.000
C03.0 Upper gum	0.009	0.991	0.000
C08.8 Overlapping lesion of major salivary glands	0.009	0.991	0.000
C08.1 Sublingual gland	0.009	0.991	0.000
C08.0 Submandibular gland	0.009	0.991	0.000
C06.0 Cheek mucosa	0.009	0.991	0.000
C03.1 Lower gum	0.009	0.991	0.000
C08.9 Major salivary gland, unspecified	0.009	0.991	0.000
C05.8 Overlapping lesion of palate	0.009	0.991	0.000
C05.2 Uvula	0.009	0.991	0.000
C05.0 Hard palate	0.009	0.991	0.000
M17.0 Primary gonarthrosis, bilateral	0.009	0.991	0.000
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.009	0.991	0.000
C09.8 Overlapping lesion of tonsil	0.009	0.991	0.000
C09.1 Tonsillar pillar (anterior) (posterior)	0.009	0.991	0.000
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.009	0.991	0.000
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.009	0.991	0.000
M06.98 Rheumatoid arthritis, unspecified (Other)	0.009	0.991	0.000
C00.9 Lip, unspecified	0.008	0.991	0.000
C00.8 Overlapping lesion of lip	0.008	0.991	0.000
C00.6 Commissure of lip	0.008	0.991	0.000
C00.5 Lip, unspecified, inner aspect	0.008	0.991	0.000
C00.4 Lower lip, inner aspect	0.008	0.991	0.000
C00.3 Upper lip, inner aspect	0.008	0.991	0.000
C00.2 External lip, unspecified	0.008	0.991	0.000
C00.1 External lower lip	0.008	0.991	0.000
C02 Malignant neoplasm of other and unspecified parts of tongue	0.008	0.991	0.000
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.008	0.992	0.000
C00.0 External upper lip	0.007	0.992	0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.007	0.993	0.000
H72.0 Central perforation of tympanic membrane	0.007	0.993	0.000
M06 Other rheumatoid arthritis	0.007	0.993	0.000
Z99.8 Dependence on other enabling machines and devices	0.000	0.993	0.007
M06.3 Rheumatoid nodule	0.007	0.993	0.000
G44.2 Tension-type headache	0.000	0.993	0.007
C02.4 Lingual tonsil	0.006	0.993	0.000
C02.8 Overlapping lesion of tongue	0.006	0.994	0.000
C02.3 Anterior two-thirds of tongue, part unspecified	0.006	0.994	0.000
C02.0 Dorsal surface of tongue	0.006	0.994	0.000
M06.34 Rheumatoid nodule (Hand)	0.006	0.994	0.000
C05.1 Soft palate	0.006	0.994	0.001
M06.4 Inflammatory polyarthropathy	0.006	0.994	0.000
C02.2 Ventral surface of tongue	0.006	0.994	0.000
C09.9 Tonsil, unspecified	0.006	0.994	0.000
Z54.0 Convalescence following surgery	0.000	0.994	0.006
M06.37 Rheumatoid nodule (Ankle and foot)	0.006	0.994	0.000
S72.10 Pertrochanteric fracture (closed)	0.000	0.994	0.006
M06.49 Inflammatory polyarthropathy (Site unspecified)	0.005	0.995	0.000
M06.8 Other specified rheumatoid arthritis	0.005	0.995	0.000
M06.2 Rheumatoid bursitis	0.005	0.995	0.000
M06.1 Adult-onset Still's disease	0.005	0.995	0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.005	0.995	0.000
M06.32 Rheumatoid nodule (Upper arm)	0.005	0.995	0.000
M06.40 Inflammatory polyarthropathy (Multiple sites)	0.005	0.995	0.000
C02.9 Tongue, unspecified	0.005	0.995	0.000
M06.39 Rheumatoid nodule (Site unspecified)	0.005	0.995	0.000
M06.38 Rheumatoid nodule (Other)	0.005	0.995	0.000
M06.36 Rheumatoid nodule (Lower leg)	0.005	0.995	0.000
M06.35 Rheumatoid nodule (Pelvic region and thigh)	0.005	0.995	0.000
M06.33 Rheumatoid nodule (Forearm)	0.005	0.995	0.000
M06.31 Rheumatoid nodule (Shoulder region)	0.005	0.995	0.000
M06.30 Rheumatoid nodule (Multiple sites)	0.005	0.995	0.000
J31.0 Chronic rhinitis	0.000	0.995	0.005
M06.48 Inflammatory polyarthropathy (Other)	0.005	0.995	0.000
M06.47 Inflammatory polyarthropathy (Ankle and foot)	0.005	0.995	0.000
M06.46 Inflammatory polyarthropathy (Lower leg)	0.005	0.995	0.000
M06.45 Inflammatory polyarthropathy (Pelvic region and thigh)	0.005	0.995	0.000
M06.44 Inflammatory polyarthropathy (Hand)	0.005	0.995	0.000
M06.43 Inflammatory polyarthropathy (Forearm)	0.005	0.995	0.000
M06.42 Inflammatory polyarthropathy (Upper arm)	0.005	0.995	0.000
M06.41 Inflammatory polyarthropathy (Shoulder region)	0.005	0.995	0.000
C02.1 Border of tongue	0.004	0.995	0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.005	0.995	0.000
G25.8 Other specified extrapyramidal and movement disorders	0.000	0.995	0.005
K72.9 Hepatic failure, unspecified	0.000	0.995	0.005
Z93.0 Tracheostomy status	0.005	0.995	0.000
C71.2 Temporal lobe	0.004	0.996	0.000
M06.19 Adult-onset Still's disease (Site unspecified)	0.004	0.996	0.000
M06.18 Adult-onset Still's disease (Other)	0.004	0.996	0.000
M06.17 Adult-onset Still's disease (Ankle and foot)	0.004	0.996	0.000
M06.16 Adult-onset Still's disease (Lower leg)	0.004	0.996	0.000
M06.15 Adult-onset Still's disease (Pelvic region and thigh)	0.004	0.996	0.000
M06.14 Adult-onset Still's disease (Hand)	0.004	0.996	0.000
M06.13 Adult-onset Still's disease (Forearm)	0.004	0.996	0.000
M06.12 Adult-onset Still's disease (Upper arm)	0.004	0.996	0.000
M06.11 Adult-onset Still's disease (Shoulder region)	0.004	0.996	0.000
M06.10 Adult-onset Still's disease (Multiple sites)	0.004	0.996	0.000
M06.29 Rheumatoid bursitis (Site unspecified)	0.004	0.996	0.000
M06.28 Rheumatoid bursitis (Other)	0.004	0.996	0.000
M06.27 Rheumatoid bursitis (Ankle and foot)	0.004	0.996	0.000
M06.26 Rheumatoid bursitis (Lower leg)	0.004	0.996	0.000
M06.25 Rheumatoid bursitis (Pelvic region and thigh)	0.004	0.996	0.000
M06.24 Rheumatoid bursitis (Hand)	0.004	0.996	0.000
M06.23 Rheumatoid bursitis (Forearm)	0.004	0.996	0.000
M06.22 Rheumatoid bursitis (Upper arm)	0.004	0.996	0.000
M06.21 Rheumatoid bursitis (Shoulder region)	0.004	0.996	0.000
M06.20 Rheumatoid bursitis (Multiple sites)	0.004	0.996	0.000
M06.89 Other specified rheumatoid arthritis (Site unspecified)	0.004	0.996	0.000
M06.88 Other specified rheumatoid arthritis (Other)	0.004	0.996	0.000
M06.87 Other specified rheumatoid arthritis (Ankle and foot)	0.004	0.996	0.000
M06.86 Other specified rheumatoid arthritis (Lower leg)	0.004	0.996	0.000
M06.85 Other specified rheumatoid arthritis (Pelvic region and thigh)	0.004	0.996	0.000
M06.84 Other specified rheumatoid arthritis (Hand)	0.004	0.996	0.000
M06.83 Other specified rheumatoid arthritis (Forearm)	0.004	0.996	0.000
M06.82 Other specified rheumatoid arthritis (Upper arm)	0.004	0.996	0.000
M06.81 Other specified rheumatoid arthritis (Shoulder region)	0.004	0.996	0.000
M06.80 Other specified rheumatoid arthritis (Multiple sites)	0.004	0.996	0.000
Z29.2 Other prophylactic chemotherapy	0.000	0.996	0.004
O26.9 Pregnancy-related condition, unspecified	0.000	0.996	0.004
T46.4 Angiotensin-converting-enzyme inhibitors	0.004	0.996	0.000
O30.0 Twin pregnancy	0.000	0.996	0.004
T46 Poisoning by agents primarily affecting the cardiovascular system	0.004	0.996	0.000
C71.9 Brain, unspecified	0.003	0.997	0.000
I24.9 Acute ischaemic heart disease, unspecified	0.000	0.997	0.003
H72 Perforation of tympanic membrane	0.003	0.997	0.000
R25.8 Other and unspecified abnormal involuntary movements	0.000	0.997	0.003
Z54 Convalescence	0.000	0.997	0.003
H72.2 Other marginal perforations of tympanic membrane	0.003	0.997	0.000
Z54.4 Convalescence following treatment of fracture	0.000	0.997	0.003
L40.5 Arthropathic psoriasis	0.000	0.997	0.003
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
D26.9 Uterus, unspecified	0.000	0.997	0.003
S72.1 Pertrochanteric fracture	0.000	0.997	0.003
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.003	0.997	0.000
H83.0 Labyrinthitis	0.000	0.997	0.003
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.997	0.000
T42.4 Benzodiazepines	0.003	0.997	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
G30.9 Alzheimer's disease, unspecified	0.000	0.997	0.003
M70.22 Olecranon bursitis-Upper arm	0.003	0.997	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.003	0.997	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
Y60.0 During surgical operation	0.000	0.997	0.003
T36-T50 Poisoning by drugs, medicaments and biological substances	0.003	0.997	0.000
C71 Malignant neoplasm of brain	0.003	0.997	0.000
T46.1 Calcium-channel blockers	0.003	0.997	0.000
M06.0 Seronegative rheumatoid arthritis	0.002	0.997	0.001
H72.8 Other perforations of tympanic membrane	0.003	0.997	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.003	0.997	0.000
I63.3 Cerebral infarction due to thrombosis of cerebral arteries	0.000	0.997	0.003
F60.9 Personality disorder, unspecified	0.003	0.997	0.000
M84.17 Nonunion of fracture [pseudarthrosis] (Ankle and foot)	0.003	0.997	0.000
H72.1 Attic perforation of tympanic membrane	0.003	0.997	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
T46.7 Peripheral vasodilators	0.003	0.997	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
M79.79 Fibromyalgia (Site unspecified)	0.003	0.997	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.003	0.997	0.000
R74.8 Abnormal levels of other serum enzymes	0.000	0.997	0.003
T46.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.997	0.000
Z54.9 Convalescence following unspecified treatment	0.000	0.997	0.003
Z54.7 Convalescence following combined treatment	0.000	0.997	0.003
Z54.3 Convalescence following psychotherapy	0.000	0.997	0.003
Z54.2 Convalescence following chemotherapy	0.000	0.997	0.003
Z54.1 Convalescence following radiotherapy	0.000	0.997	0.003
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.003	0.997	0.000
F00.9 Dementia in Alzheimer's disease, unspecified	0.000	0.997	0.003
O47.9 False labour, unspecified	0.000	0.997	0.003
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.997	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.997	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.997	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.997	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.997	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.997	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.997	0.000
T44.0 Anticholinesterase agents	0.002	0.997	0.000
H47.3 Other disorders of optic disk	0.003	0.997	0.000
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system	0.000	0.997	0.003
Z30.1 Insertion of (intra-uterine) contraceptive device	0.000	0.997	0.003
K85.9 Acute pancreatitis, unspecified	0.000	0.997	0.003
S72.11 Pertrochanteric fracture (open)	0.000	0.997	0.002
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
T45.0 Antiallergic and antiemetic drugs	0.003	0.997	0.000
Z54.8 Convalescence following other treatment	0.000	0.997	0.002
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
G37.9 Demyelinating disease of central nervous system, unspecified	0.000	0.997	0.003
L89.9 Decubitus ulcer and pressure area, unspecified	0.000	0.997	0.003
S63.4 Traumatic rupture of ligament of finger at metacarpophalangeal and interphalangeal joint(s)	0.000	0.997	0.002
T45.2 Vitamins, not elsewhere classified	0.002	0.998	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.002	0.998	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.002	0.998	0.000
M21.26 Flexion deformity (Lower leg)	0.002	0.998	0.000
O66.5 Failed application of vacuum extractor and forceps, unspecified	0.000	0.998	0.002
T40.6 Other and unspecified narcotics	0.002	0.998	0.000
C71.7 Brain stem	0.002	0.998	0.000
C71.6 Cerebellum	0.002	0.998	0.000
C71.5 Cerebral ventricle	0.002	0.998	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.002	0.998	0.000
I86.4 Gastric varices	0.002	0.998	0.000
G44 Other headache syndromes	0.000	0.998	0.002
M06.08 Seronegative rheumatoid arthritis (Other)	0.002	0.998	0.001
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)	0.002	0.998	0.001
M06.04 Seronegative rheumatoid arthritis (Hand)	0.002	0.998	0.001
M06.03 Seronegative rheumatoid arthritis (Forearm)	0.002	0.998	0.001
M06.02 Seronegative rheumatoid arthritis (Upper arm)	0.002	0.998	0.001
M06.01 Seronegative rheumatoid arthritis (Shoulder region)	0.002	0.998	0.001
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.002	0.998	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.002	0.998	0.000
T42.3 Barbiturates	0.002	0.998	0.000
T42.2 Succinimides and oxazolidinediones	0.002	0.998	0.000
C71.3 Parietal lobe	0.002	0.998	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
M06.06 Seronegative rheumatoid arthritis (Lower leg)	0.002	0.998	0.000
J31 Chronic rhinitis, nasopharyngitis and pharyngitis	0.000	0.998	0.002
T38.1 Thyroid hormones and substitutes	0.002	0.998	0.000
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)	0.002	0.998	0.001
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.002	0.998	0.000
C71.4 Occipital lobe	0.002	0.998	0.000
T47.0 Histamine H(2)-receptor antagonists	0.002	0.998	0.000
M94.86 Other specified disorders of cartilage (Lower leg)	0.000	0.998	0.002
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
T50.8 Diagnostic agents	0.002	0.998	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.002	0.998	0.000
G37 Other demyelinating diseases of central nervous system	0.000	0.998	0.002
M47.99 Spondylosis, unspecified (Site unspecified)	0.000	0.998	0.002
T81.5 Foreign body accidentally left in body cavity or operation wound following a procedure	0.002	0.998	0.000
N60.4 Mammary duct ectasia	0.002	0.998	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.002	0.998	0.000
T45.8 Other primarily systemic and haematological agents	0.002	0.998	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
T45.6 Fibrinolysis-affecting drugs	0.002	0.998	0.000
T45.4 Iron and its compounds	0.002	0.998	0.000
T45.3 Enzymes, not elsewhere classified	0.002	0.998	0.000
T36 Poisoning by systemic antibiotics	0.002	0.998	0.000
C71.8 Overlapping lesion of brain	0.002	0.998	0.000
K13.7 Other and unspecified lesions of oral mucosa	0.000	0.998	0.002
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
M21.27 Flexion deformity (Ankle and foot)	0.002	0.998	0.000
F00 Dementia in Alzheimer's disease	0.000	0.998	0.002
G44.4 Drug-induced headache, not elsewhere classified	0.000	0.998	0.002
T50.7 Analeptics and opioid receptor antagonists	0.002	0.998	0.000
T50.5 Appetite depressants	0.002	0.998	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
T50.1 Loop [high-ceiling] diuretics	0.002	0.998	0.000
T50.0 Mineralocorticoids and their antagonists	0.002	0.998	0.000
G37.8 Other specified demyelinating diseases of central nervous system	0.000	0.998	0.002
M21.2 Flexion deformity	0.002	0.998	0.000
T40.5 Cocaine	0.002	0.998	0.000
T43.9 Psychotropic drug, unspecified	0.002	0.998	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
J39.2 Other diseases of pharynx	0.002	0.998	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
T45.5 Anticoagulants	0.002	0.998	0.000
T50.4 Drugs affecting uric acid metabolism	0.002	0.998	0.000
T42.0 Hydantoin derivatives	0.002	0.998	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
M21.24 Flexion deformity (Hand)	0.002	0.998	0.000
N64.4 Mastodynia	0.000	0.998	0.002
C71.0 Cerebrum, except lobes and ventricles	0.002	0.998	0.000
H47.1 Papilloedema, unspecified	0.002	0.998	0.000
I89.8 Other specified non-infective disorders of lymphatic vessels and lymph nodes	0.000	0.998	0.002
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
T47.7 Emetics	0.002	0.998	0.000
T47.6 Antidiarrhoeal drugs	0.002	0.998	0.000
T47.5 Digestants	0.002	0.998	0.000
T47.4 Other laxatives	0.002	0.998	0.000
T47.3 Saline and osmotic laxatives	0.002	0.998	0.000
T47.2 Stimulant laxatives	0.002	0.998	0.000
T49.9 Topical agent, unspecified	0.002	0.998	0.000
T49.8 Other topical agents	0.002	0.998	0.000
T49.7 Dental drugs, topically applied	0.002	0.998	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
T49.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
T49.3 Emollients, demulcents and protectants	0.002	0.998	0.000
T49.2 Local astringents and local detergents	0.002	0.998	0.000
T49.1 Antipruritics	0.002	0.998	0.000
F01.9 Vascular dementia, unspecified	0.000	0.998	0.002
I89.0 Lymphoedema, not elsewhere classified	0.000	0.998	0.002
J31.1 Chronic nasopharyngitis	0.000	0.998	0.002
T41.5 Therapeutic gases	0.002	0.998	0.000
T41.4 Anaesthetic, unspecified	0.002	0.998	0.000
T41.3 Local anaesthetics	0.002	0.998	0.000
T41.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
T41.1 Intravenous anaesthetics	0.002	0.998	0.000
T41.0 Inhaled anaesthetics	0.002	0.998	0.000
M06.09 Seronegative rheumatoid arthritis (Site unspecified)	0.001	0.998	0.001
S42.30 Fracture of shaft of humerus (closed)	0.000	0.998	0.002
G44.1 Vascular headache, not elsewhere classified	0.000	0.998	0.002
T38.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
T38.7 Androgens and anabolic congeners	0.002	0.998	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
T38.5 Other oestrogens and progestogens	0.002	0.998	0.000
T38.4 Oral contraceptives	0.002	0.998	0.000
T38.2 Antithyroid drugs	0.002	0.998	0.000
T38.0 Glucocorticoids and synthetic analogues	0.002	0.998	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
G44.3 Chronic posttraumatic headache	0.000	0.998	0.002
F02.0 Dementia in Pick's disease	0.000	0.998	0.002
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.002	0.998	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.998	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
T48.5 Anti-common-cold drugs	0.002	0.998	0.000
T48.4 Expectorants	0.002	0.998	0.000
T48.3 Antitussives	0.002	0.998	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
T48.0 Oxytocic drugs	0.002	0.998	0.000
M07.39 Other psoriatic arthropathies (Site unspecified)	0.000	0.998	0.002
S19.9 Unspecified injury of neck	0.002	0.998	0.000
G25.9 Extrapyramidal and movement disorder, unspecified	0.000	0.998	0.002
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.002	0.998	0.000
T40.8 Lysergide [LSD]	0.002	0.998	0.000
T40.7 Cannabis (derivatives)	0.002	0.998	0.000
T40.3 Methadone	0.002	0.998	0.000
T40.1 Heroin	0.002	0.998	0.000
T40.0 Opium	0.002	0.998	0.000
F02 Dementia in other diseases classified elsewhere	0.000	0.998	0.002
M76.66 Achilles tendinitis (Lower leg)	0.002	0.998	0.000
H53.1 Subjective visual disturbances	0.000	0.998	0.002
T43.6 Psychostimulants with abuse potential	0.002	0.998	0.000
G30 Alzheimer's disease	0.000	0.998	0.002
K72 Hepatic failure, not elsewhere classified	0.000	0.998	0.002
G37.5 Concentric sclerosis [Balo]	0.000	0.998	0.002
G37.4 Subacute necrotising myelitis	0.000	0.998	0.002
G37.2 Central pontine myelinolysis	0.000	0.998	0.002
G37.1 Central demyelination of corpus callosum	0.000	0.998	0.002
G37.0 Diffuse sclerosis	0.000	0.998	0.002
O34.2 Maternal care due to uterine scar from previous surgery	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
T37.5 Antiviral drugs	0.002	0.998	0.000
T37.4 Anthelminthics	0.002	0.998	0.000
T37.3 Other antiprotozoal drugs	0.002	0.998	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
T37.1 Antimycobacterial drugs	0.002	0.998	0.000
T37.0 Sulphonamides	0.002	0.998	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
G25 Other extrapyramidal and movement disorders	0.000	0.998	0.002
F02.8 Dementia in other specified diseases classified elsewhere	0.000	0.998	0.002
H47 Other disorders of optic [2nd] nerve and visual pathways	0.002	0.998	0.000
J31.2 Chronic pharyngitis	0.000	0.998	0.002
T36.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
T36.8 Other systemic antibiotics	0.002	0.998	0.000
T36.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
T36.6 Rifamycins	0.002	0.998	0.000
T36.5 Aminoglycosides	0.002	0.998	0.000
T36.4 Tetracyclines	0.002	0.998	0.000
T36.3 Macrolides	0.002	0.998	0.000
T36.2 Chloramphenicol group	0.002	0.998	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.002	0.998	0.000
G44.0 Cluster headache syndrome	0.000	0.998	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
F00.2 Dementia in Alzheimer's disease, atypical or mixed type	0.000	0.998	0.002
F00.0 Dementia in Alzheimer's disease with early onset	0.000	0.998	0.002
T42.1 Iminostilbenes	0.002	0.998	0.000
F00.1 Dementia in Alzheimer's disease with late onset	0.000	0.998	0.002
H65.9 Nonsuppurative otitis media, unspecified	0.002	0.998	0.000
I62.0 Subdural haemorrhage (acute) (nontraumatic)	0.002	0.998	0.000
F01 Vascular dementia	0.000	0.998	0.002
W13.9 Unspecified place	0.000	0.998	0.002
M21.29 Flexion deformity (Site unspecified)	0.002	0.998	0.000
M21.28 Flexion deformity (Other)	0.002	0.998	0.000
M21.25 Flexion deformity (Pelvic region and thigh)	0.002	0.998	0.000
M21.23 Flexion deformity (Forearm)	0.002	0.998	0.000
M21.22 Flexion deformity (Upper arm)	0.002	0.998	0.000
M21.21 Flexion deformity (Shoulder region)	0.002	0.998	0.000
M21.20 Flexion deformity (Multiple sites)	0.002	0.998	0.000
M21.37 Wrist or foot drop (acquired) (Ankle and foot)	0.002	0.998	0.000
C71.1 Frontal lobe	0.002	0.998	0.000
T43.2 Other and unspecified antidepressants	0.002	0.998	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
I62.9 Intracranial haemorrhage (nontraumatic), unspecified	0.002	0.998	0.000
M94.8 Other specified disorders of cartilage	0.000	0.998	0.002
N64.8 Other specified disorders of breast	0.000	0.998	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.001	0.998	0.000
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.001	0.998	0.000
G30.8 Other Alzheimer's disease	0.000	0.998	0.002
G30.0 Alzheimer's disease with early onset	0.000	0.998	0.002
F60.3 Emotionally unstable personality disorder	0.002	0.998	0.000
M13.90 Arthritis, unspecified (Multiple sites)	0.002	0.998	0.000
M94.89 Other specified disorders of cartilage (Site unspecified)	0.000	0.998	0.002
F02.4 Dementia in human immunodeficiency virus [HIV] disease	0.000	0.998	0.001
F02.2 Dementia in Huntington's disease	0.000	0.998	0.001
F02.1 Dementia in Creutzfeldt-Jakob disease	0.000	0.998	0.001
K51.3 Ulcerative (chronic) rectosigmoiditis	0.000	0.998	0.002
T36.0 Penicillins	0.001	0.998	0.000
F00-F09 Organic, including symptomatic, mental disorders	0.000	0.998	0.002
F02.3 Dementia in Parkinson's disease	0.000	0.998	0.002
G25.6 Drug-induced tics and other tics of organic origin	0.000	0.998	0.001
G25.5 Other chorea	0.000	0.998	0.001
G25.4 Drug-induced chorea	0.000	0.998	0.001
G25.1 Drug-induced tremor	0.000	0.998	0.001
H47.7 Disorder of visual pathways, unspecified	0.001	0.998	0.000
H47.6 Disorders of visual cortex	0.001	0.998	0.000
H47.5 Disorders of other visual pathways	0.001	0.998	0.000
H47.4 Disorders of optic chiasm	0.001	0.998	0.000
M70.2 Olecranon bursitis	0.002	0.998	0.000
M94.88 Other specified disorders of cartilage (Other)	0.000	0.998	0.002
J15.1 Pneumonia due to Pseudomonas	0.000	0.998	0.002
T40.4 Other synthetic narcotics	0.002	0.998	0.000
O30 Multiple gestation	0.000	0.998	0.002
K72.0 Acute and subacute hepatic failure	0.000	0.998	0.002
F03 Unspecified dementia	0.000	0.998	0.002
F60 Specific personality disorders	0.002	0.998	0.000
F01.8 Other vascular dementia	0.000	0.998	0.001
F01.3 Mixed cortical and subcortical vascular dementia	0.000	0.998	0.001
F01.2 Subcortical vascular dementia	0.000	0.998	0.001
F01.1 Multi-infarct dementia	0.000	0.998	0.001
F01.0 Vascular dementia of acute onset	0.000	0.998	0.001
M65.44 Radial styloid tenosynovitis [de Quervain] (Hand)	0.002	0.998	0.000
G44.8 Other specified headache syndromes	0.000	0.998	0.001
H47.2 Optic atrophy	0.001	0.998	0.000
I44.0 Atrioventricular block, first degree	0.002	0.998	0.000
R70.0 Elevated erythrocyte sedimentation rate	0.002	0.998	0.000
E86 Volume depletion	0.000	0.998	0.002
M17.5 Other secondary gonarthrosis	0.002	0.998	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.001	0.998	0.001
M94.87 Other specified disorders of cartilage (Ankle and foot)	0.000	0.998	0.001
M94.85 Other specified disorders of cartilage (Pelvic region and thigh)	0.000	0.998	0.001
M94.84 Other specified disorders of cartilage (Hand)	0.000	0.998	0.001
M94.83 Other specified disorders of cartilage (Forearm)	0.000	0.998	0.001
M94.82 Other specified disorders of cartilage (Upper arm)	0.000	0.998	0.001
M94.81 Other specified disorders of cartilage (Shoulder region)	0.000	0.998	0.001
M94.80 Other specified disorders of cartilage (Multiple sites)	0.000	0.998	0.001
J15.7 Pneumonia due to Mycoplasma pneumoniae	0.000	0.998	0.002
I89 Other non-infective disorders of lymphatic vessels and lymph nodes	0.000	0.998	0.002
G30.1 Alzheimer's disease with late onset	0.000	0.998	0.001
K72.1 Chronic hepatic failure	0.000	0.998	0.001
N76.2 Acute vulvitis	0.000	0.998	0.001
H83 Other diseases of inner ear	0.000	0.998	0.001
C72.0 Spinal cord	0.001	0.998	0.000
S72.80 Fractures of other parts of femur (closed)	0.000	0.999	0.001
R90.8 Other abnormal findings on diagnostic imaging of central nervous system	0.000	0.999	0.001
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.001	0.999	0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.001	0.999	0.000
H47.0 Disorders of optic nerve, not elsewhere classified	0.001	0.999	0.000
I89.9 Non-infective disorder of lymphatic vessels and lymph nodes, unspecified	0.000	0.999	0.001
Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care	0.000	0.999	0.001
M70.29 Olecranon bursitis-Site unspec	0.001	0.999	0.000
M70.28 Olecranon bursitis-Other	0.001	0.999	0.000
M70.27 Olecranon bursitis-Ankle/Foot	0.001	0.999	0.000
M70.26 Olecranon bursitis-Lower Leg	0.001	0.999	0.000
M70.25 Olecranon bursitis-Pelvic/Thigh	0.001	0.999	0.000
M70.24 Olecranon bursitis-Hand	0.001	0.999	0.000
M70.23 Olecranon bursitis-Forearm	0.001	0.999	0.000
M70.21 Olecranon bursitis-Shldr region	0.001	0.999	0.000
M70.20 Olecranon bursitis-Mult sites	0.001	0.999	0.000
O30.9 Multiple gestation, unspecified	0.000	0.999	0.001
O30.8 Other multiple gestation	0.000	0.999	0.001
O30.2 Quadruplet pregnancy	0.000	0.999	0.001
O30.1 Triplet pregnancy	0.000	0.999	0.001
W06.0 Home	0.001	0.999	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.001	0.999	0.000
C70 Malignant neoplasm of meninges	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations